What's behind Abbott's latest 1.6% stock pullback?

Traders Union
All News
Stocks
Abbott Laboratories slides 1.57% today

Highlights

Shares of Abbott trade below key moving averages, confirming strong downward pressure across short, medium, and long-term trends.
Technical indicators including MACD, ADX, RSI, Stochastic RSI, and CCI all predict a continued downside and oversold conditions.
Abbott stock is expected to trade in a $99.31 to $102.75 range over the next five sessions, with a 71% probability of further decline.

Anton Kharitonov, expert at Traders Union, sees sustained technical weakness in Abbott Laboratories. He notes the absence of any supportive news, which amplifies negative sentiment. Price remains stuck below all key moving averages, with momentum indicators overwhelmingly bearish. The risk of further declines is high, and failed attempts to reclaim resistance reinforce a defensive outlook. "With the stock entrenched in a downtrend and no positive catalysts in sight, caution is imperative for investors at current levels."

Viktoras Karapetjanc, expert at Traders Union, views the current weakness in Abbott as a temporary interruption within a larger opportunity set. He highlights that the lack of fresh news flow creates potential for sharp reactions if positive updates arrive. Further growth is possible should the price reclaim $102.75, which would reestablish bullish momentum. "Despite recent downside, the market offers multiple setups for buyers who anticipate positive developments and a rebound above resistance."

Jainam Mehta, market strategist, notes a clear technical breakdown but sees tactical interest near support at $99.31. He points out that oversold readings across several momentum oscillators may set the stage for a short-term bounce. Contrarian traders could watch for a reversal above $102.75 as a signal of potential strength. "If sellers lose conviction near support, I expect opportunistic entries to trigger a swift technical rebound."

Persistent weakness as key averages breached and momentum turns negative

Abbott trades well below its key daily moving averages, with the current price of $100.75 holding under the 20-day ($109.33), 50-day ($105.71), and 200-day ($105.46) levels. This structure reflects persistent downward pressure across short-, medium-, and long-term trends, and the Ichimoku Kijun at $109.38 now represents distant resistance. Closest price resistance for Abbott is at $101.47, with the nearest support at $99.31. Technical momentum indicators point to sustained downside. Both MACD and ADX signal 'Sell', while the RSI is at 36.14, approaching oversold territory. Stochastic RSI and CCI also display oversold conditions. Bull/Bear Power (BBP) is negative at -2.37 and reveals sellers in control of intraday activity. The Awesome Oscillator forecasts ongoing decline. The stock opened with a minor downside gap and has continued to trade toward session lows, while intraday volatility was measured at 0.23%.

Earlier, analysts noted that Abbott Laboratories faced persistent selling pressure with technical signals pointing to continued short- and long-term weakness despite some stabilization efforts. The current technical breakdown reinforces this bearish outlook, with traders advised to monitor the $99.31 support as a potential tipping point for accelerated downside risk.

Source of Data: ABT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.